These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2887665

  • 1. Differential effect of mu, delta, and kappa opioid agonists on adenylate cyclase activity.
    De Montis GM, Devoto P, Preti A, Tagliamonte A.
    J Neurosci Res; 1987; 17(4):435-9. PubMed ID: 2887665
    [Abstract] [Full Text] [Related]

  • 2. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN.
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of opioid receptor agonists on nociception and cAMP level in the spinal cord of monoarthritic rats.
    Przewłocka B, Dziedzicka M, Lasoń W, Przewłocki R.
    Life Sci; 1992 Jun; 50(1):45-54. PubMed ID: 1345879
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Characterization of opioid receptors modulating the function of capsaicin-sensitive neurons in guinea-pig atria.
    Mantelli L, Amerini S, Rubino A, Ledda F.
    Eur J Pharmacol; 1990 May 16; 180(2-3):325-30. PubMed ID: 1973118
    [Abstract] [Full Text] [Related]

  • 6. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP, Leone P, Pocock D, Wise RA.
    J Pharmacol Exp Ther; 1993 Sep 16; 266(3):1236-46. PubMed ID: 7690399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR, Makhlouf GM.
    Am J Physiol; 1991 Jan 16; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [Abstract] [Full Text] [Related]

  • 9. Bremazocine differentially antagonizes responses to selective mu and delta opioid receptor agonists in rat hippocampus.
    Dunwiddie TV, Johnson KJ, Proctor WR.
    Br J Pharmacol; 1987 Jul 16; 91(3):523-30. PubMed ID: 3038241
    [Abstract] [Full Text] [Related]

  • 10. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
    de Costa BR, Rothman RB, Bykov V, Band L, Pert A, Jacobson AE, Rice KC.
    J Med Chem; 1990 Apr 16; 33(4):1171-6. PubMed ID: 2157008
    [Abstract] [Full Text] [Related]

  • 11. Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain.
    De Vries TJ, Hogenboom F, Mulder AH, Schoffelmeer AN.
    Brain Res Dev Brain Res; 1990 Jun 01; 54(1):63-9. PubMed ID: 2163782
    [Abstract] [Full Text] [Related]

  • 12. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
    Van Vliet BJ, Mulder AH, Schoffelmeer AN.
    J Neurochem; 1990 Oct 01; 55(4):1274-80. PubMed ID: 2168934
    [Abstract] [Full Text] [Related]

  • 13. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H, Misawa H, Fukushima N, Takagi H.
    Eur J Pharmacol; 1987 Jun 12; 138(1):129-32. PubMed ID: 3040426
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC, Onali P.
    Mol Pharmacol; 1992 Jul 12; 42(1):109-15. PubMed ID: 1321951
    [Abstract] [Full Text] [Related]

  • 18. Central effects of mu, delta, and kappa receptor agonists in hemorrhagic shock.
    Feuerstein G, Powell E, Faden AI.
    Peptides; 1985 Jul 12; 6 Suppl 1():11-3. PubMed ID: 2995939
    [Abstract] [Full Text] [Related]

  • 19. Autoradiographic localization in rat brain of kappa opiate binding sites labelled by [3H]bremazocine.
    Morris BJ, Herz A.
    Neuroscience; 1986 Nov 12; 19(3):839-46. PubMed ID: 3025770
    [Abstract] [Full Text] [Related]

  • 20. Delta and kappa opiate receptors in primary astroglial cultures. Part II: Receptor sets in cultures from various brain regions and interactions with beta-receptor activated cyclic AMP.
    Eriksson PS, Hansson E, Rönnbäck L.
    Neurochem Res; 1992 Jun 12; 17(6):545-51. PubMed ID: 1318509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.